Les 10 concurrents cellcarta.com les plus visités

nuvisan.com

fully integrated cro/cdmo, with a 40-year track record of serving pharmaceutical and biotech companies.

ppd.com

Tap into insights on how to embrace a patient diversity mindset from Rodrigo Garcia, Vice President, Sites and Patients Center of Excellence, PPD clinical research business of Thermo Fisher Scientific.

qps.com

Humans have practiced oncology — the study and treatment of cancer — since long before the invention of the scalpel.

patheon.com

With more than 60 locations across 25 countries, we provide a global network of experts and pharma services to support every phase of your development journey.

cmicgroup.com

シミックグループは、日本におけるCRO（医薬品開発支援）のパイオニアとして、グループ独自の事業モデル「PVC: Pharmaceutical Value Creator」を展開し、開発から製造、営業・マーケティングなど、製薬企業のバリューチェーンをすべて支援できる体制を整えています。

celerion.com

Celerion is committed to implementing innovative strategies with applied translational medicine to gain insights on early drug development decisions. We provide vital expertise and experience in a large clinical capacity to ensure our clients are getting their product to the market faster.

clinicalink.com

Clinical ink offers advanced electronic data capture (EDC) solutions for esource clinical trials.

novotech-cro.com

Triple-Negative Breast Cancer (TNBC) is a highly aggressive and heterogeneous subtype of breast cancer This FAQ section explores its incidence, ongoing trials, innovative drug therapies, and their impact on patient outcomes. 1. What makes TNBC different from other breast cancer subtypes?

inizio.com

Learn more about Inizio's Data Privacy Framework Policy and how it collects, use, and discloses certain personally identifiable information.

biolabs.io

BioLabs empowers innovation worldwide by offering life science entrepreneurs a premier innovation support platform centered around fully supported co-working lab facilities for biotech startups and access to a global network of partners. BioLabs is located in key innovation clusters worldwide, including Boston, Cambridge, New Haven, New York City, Princeton, Philadelphia, Raleigh-Durham, Dallas, San Diego, Los Angeles, Paris, Paris-Saclay, Heidelberg, Berlin, and Kawasaki.